Workflow
Benzinga
icon
搜索文档
General Motors To Rally More Than 27%? Here Are 10 Top Analyst Forecasts For Wednesday - Boeing (NYSE:BA), Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 2026-01-28 22:14
华尔街分析师评级变动 - 顶级华尔街分析师改变了对部分知名公司的展望 [1] - 完整的分析师评级变动包括升级和降级 [1] 通用汽车公司 - 分析师对是否买入通用汽车股票持有观点 [1]
Amazon Just Scrapped 'Fresh' To Bring The Fight Straight To Walmart
Benzinga· 2026-01-28 22:09
公司战略调整 - 亚马逊关闭了Amazon Fresh和Amazon Go等实验性业态 将资本重新配置到更具确定性的领域 [1] - 公司计划进行一项100家门店的Whole Foods扩张 并探索新的实体“零售超级中心”概念 [1] - 这一战略转向标志着公司资本配置更加严格 零售战略更加清晰 不再追逐实验性业态 而是整合到能够驱动销量、数据和Prime会员参与度的资产上 [6] 业务表现与优化 - Amazon Fresh业务运营成本高昂 扩张缓慢 未能显著侵蚀沃尔玛的核心杂货市场份额 [2] - 关闭该业务可释放资本 用于那些真正能带动销量的业态 [2] - 在生鲜品类取得突破 自2025年初以来 同日送达的生鲜销售额增长了40倍 超快配送可将牛奶和鸡蛋等主食在30分钟内送达 [3] - 更快的配送增加了购买频率、客单价和Prime会员的粘性 这些都是客户终身价值的关键驱动因素 [4] 新业态与竞争格局 - Whole Foods门店正在转变为高利润的物流枢纽 而不仅仅是高端杂货卖场 [3] - 公司正探索自有的大卖场超级中心模式 将杂货、必需品和一般商品置于同一屋檐下 这效仿了沃尔玛的策略 但背后有亚马逊的物流和数据能力支持 [5] - 沃尔玛在美国拥有4700多家门店 规模优势显著 而亚马逊的赌注不同 其门店数量更少 利润率更高 并叠加了最后一英里配送的经济模型 [6] - 亚马逊正在有选择性地购买实体店密度 并专注于利润率更高的地产 [5] - 此次战略调整意味着与沃尔玛的竞争已从理论进入实战部署阶段 [6]
Rising AI Infrastructure Demand Paints A Nuanced Tale For Direxion's AVGO-Focused Bull, Bear ETFs
Benzinga· 2026-01-28 21:47
博通公司股票表现 - 过去52周内,博通股票涨幅超过35%,受益于机器学习应用的广泛普及[1] - 在上涨势头高峰期,公司股价曾突破400美元的关键技术位[1] - 自2021年3月以来,公司仅两次未达到营收预期,且从未低于每股收益的共识预期,表现出极强的业绩一致性[2] 人工智能与半导体行业动态 - 人工智能已从新奇事物转变为不可或缺的创新,推动了相关公司的增长[1] - 分析师认为人工智能周期可能仍有发展空间,这有助于缓解半导体行业剧烈的周期性波动[3] Direxion交易所交易基金产品 - Direxion推出了两只与博通相关的、方向相反的交易所交易基金,允许交易者对不同市场叙事进行押注[3][9] - 这些ETF主要吸引零售投机者,因其提供类似普通公开交易证券的买卖灵活性,无需涉足复杂的期权等衍生品市场[4] - 看涨的AVL ETF自本月以来表现不佳,下跌了13%[6] - 看跌的AVS ETF自1月初以来表现稳健,上涨了近6%[7] 技术分析要点 - AVL ETF的日线图显示其自12月以来一直承压,50日移动平均线对其价格走势构成上行阻力[10] - AVL ETF的周线图中,经过缩放的20日指数移动平均线构成上行阻力,但50日移动平均线似乎对股价构成支撑[10] - AVS ETF的日线图显示其在12月突破了20日指数移动平均线和50日移动平均线,目前这两条均线构成支撑[10] - AVS ETF的周线图中,经过缩放的20日指数移动平均线构成上行阻力,是多头面临的下一个挑战[10]
Top 2 Consumer Stocks That May Keep You Up At Night In January
Benzinga· 2026-01-28 21:45
As of Jan. 28, 2026, two stocks in the consumer discretionary sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, acc ...
This Oklo Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Apellis Pharmaceuticals (NASDAQ:APLS), Bloom Energy (NYSE:BE)
Benzinga· 2026-01-28 21:41
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying OKLO stock? Here’s what analysts think: Photo via Shutterstock ...
Wall Street's Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 3% Dividend Yields
Benzinga· 2026-01-28 21:35
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.Below are the ratings of the most accurate analysts for three high-yield ...
EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal
Benzinga· 2026-01-28 21:31
ENvue Medical Inc. (NASDAQ:FEED) on Wednesday announced that it has inked a distribution agreement with U-Deliver to distribute ENvue's recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels.The over-the-counter ENFit Syringes are designed to meet both feeding and medication delivery clinical needs.ENvue Medical, rebranded from NanoVibronix Inc., is a medical technology company specializing in the advancement of intelligent, non-invasive solutions ...
How To Earn $500 A Month From Microsoft Stock Ahead Of Q2 Earnings
Benzinga· 2026-01-28 21:16
财报发布与预期 - 微软公司将于1月28日周三收盘后发布第二财季财报 [1] - 市场普遍预期公司每股收益为3.97美元,较去年同期的3.23美元有所增长 [1] - 市场普遍预期公司季度营收为802.7亿美元,去年同期为696.3亿美元 [1] - 美国银行证券分析师Brad Sills维持“买入”评级,但将目标价从640美元下调至520美元 [1] 股息收益与计算 - 微软目前的年度股息收益率为0.76%,季度股息为每股0.91美元(年度3.64美元) [2] - 若想通过股息每月获得500美元收入(年6000美元),需持有约1648股微软股票 [2] - 持有1648股微软股票,按当前股价计算,约需投入79.1996万美元 [3] - 若目标为每月100美元股息收入(年1200美元),则需持有约330股,投入约15.8591万美元 [3] 股价与股息收益率动态 - 股息收益率由年度股息支付除以当前股价计算得出,会随股价波动而变化 [4] - 例如,股价上涨将导致股息收益率下降,股价下跌则导致收益率上升 [4] - 股息支付额本身也可能随时间调整,进而影响股息收益率 [5] - 在财报发布前一日(1月27日周二),微软股价上涨2.2%,收于480.58美元 [5]
Pinterest Tops Growth Despite Announcing Restructuring And Job Cuts
Benzinga· 2026-01-28 21:13
Pinterest Inc. (NYSE:PINS) has surged into the upper echelon of growth stocks, according to Benzinga Edge data. However, it still faces significant bearish pressure, prompting a massive 15% workforce reduction and a strategic pivot toward AI to reverse its slumping price trends.Data Divergence: Elite Growth, Bottom-Tier MomentumThe latest Benzinga Edge rankings highlight a stark paradox in Pinterest’s profile. The company's growth score has jumped to 95.09, placing it in the 95th percentile against peers.Th ...
Qorvo, Altimmune, United Microelectronics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Altimmune (NASDAQ:ALT), Elevance Health (NYSE:ELV)
Benzinga· 2026-01-28 21:05
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining more than 200 points on Wednesday.Shares of Qorvo, Inc. (NASDAQ:QRVO) fell sharply in pre-market trading after the company reported third-quarter financial results and issued fourth-quarter sales guidance below estimates.Qorvo shares expects fiscal fourth-quarter revenue to be in the range of $775 million to $825 million versus estimates of $904.59 million. The company anticipates adjusted earnings of $1.05 to $1.35 per share i ...